Filter posts

Coming Down the Pipeline: Patent Cases to Watch in 2017

The Supreme Court returns from recess on February 17, and alongside the likely confirmation of …

Registration for BIO's Spring IP Counsels Committee Conference is now OPEN!

Tired of those pea-coats and earmuffs? Wish you were lying on a beach right now, …

ICYMI: Tom Daschle Proposes Biodefense Role for Mike Pence

Featured in The Hill last week was Tom Daschle – former United States Senate Majority Leader …

New York Legislators to PTO Head: Stop IPR Abuse

This week ten members the U.S. House of Representatives from New York wrote to U.S. …

MassBio Releases Statement Following Cost Trends Hearings

MassBio issues this statement, following the Massachusetts’ Health Policy Commission’s (HPC) hearing earlier this week on …

Five Oncologists Weigh in on Value Frameworks

Value Frameworks, which attempt to quantify the value of a medicine, have been a hot …

Patent Reform Needs to Address Trolling of All Stripes

As we enter the final days of the 114th Congress, it is regrettable that the …

What They’re Saying about the Medicare Part B Demo

Back in March, CMS’s Center for Medicare and Medicaid Innovation (CMMI) proposed a sweeping demonstration …

NORD President: Congress must act now to help 15 million sick children

Writing in The Hill, National Organization for Rare Disorders (NORD) President and CEO Peter Saltonstall …

PTAB, IPRs and Uncertainty in the Patent System

The topic of inter partes reviews (IPRs) has dominated conversation in patent circles for the …